Refresh

Biocon Ltd.

Price on BSE   05 Mar,15:29 LIVE
389.00
+10.75
(+2.84%)

© 2026 Rediff.com
  • Volume :
  • 164,559.00
  • Prev Close :
  • 378.25
  • Day's H/L (Rs.) :
  • 389.00 - 379.15
  • 52wk H/L (Rs.) :
  • 424.95 - 295.30
  • Mkt Cap (Rs. Cr) :
  • 63,053.02
Price on NSE   05 Mar,15:59 LIVE
386.80
+8.45
(+2.23%)

© 2026 Rediff.com
  • Volume :
  • 2,832,306.00
  • Prev Close :
  • 378.35
  • Day's H/L (Rs.) :
  • 389.00 - 379.65
  • 52wk H/L (Rs.) :
  • 424.95 - 297.40
  • Mkt Cap (Rs. Cr) :
  • 0.00

View more

Market News

Abbott Bets On Semaglutide Boom
Rediff.com   5 day(s) ago
Biocon launches diabetes & obesity drugs in Netherlands
Rediff.com   16 Dec 2025
10 Stocks That May Gain From Budget
Rediff.com   04 Feb 2026
'We're 2 biggest fugitives': Lalit Modi, Mallya mock India
Rediff.com   24 Dec 2025
Report Card - Biocon Ltd.
PE Ratios
76.65
EPS (Rs.)
5.07
Sales (Rs. Cr)
621.30
Face Value (Rs.)
5
Net Profit Margin(%)
27.16
Last Bonus
1:1
Last Dividend(%)
10
Return on Average Equity
5.28

News for Biocon Ltd.

BahiaFarma, Biocon, Bionovis Ink Pharma MoU
BahiaFarma, Biocon, and Bionovis sign MoU for medicine development. NMDC, Vale SA, and Adani Gangavaram Port Ltd also sign MoU.
Feb 21, 2026 20:32
AI & Biological Intelligence: Healthcare
Kiran Mazumdar-Shaw highlights how AI and biological intelligence convergence can transform healthcare, enabling predictive medicine.
Feb 20, 2026 13:51
Biocon Q3 Profit Surges to Rs 144 Cr
Biocon reports a five-fold jump in Q3 net profit to Rs 144 crore, driven by generics and biosimilars. Revenue increased to Rs 4,173 crore.
Feb 12, 2026 21:37
Biopharma Shakti: Investment in India's Health
Industry leaders hail Rs 10,000-cr Biopharma Shakti as a decisive investment in India's health and innovation future.
Feb 01, 2026 17:47
Budget 2026-27: India Inc on Economy & Competitiveness
India Inc hails Union Budget 2026-27 for boosting economy, enhancing India's global competitiveness, and focusing on structural reforms.
Feb 01, 2026 17:02

More News for Biocon Ltd. »

News for Pharmaceuticals and health care

Delhi Excise Revenue: Rs 4,992 Crore
Delhi excise department collected Rs 4,992 crore revenue by January-end. Revised target is Rs 6,000 crore by March. Details here.
Mar 06, 2026 00:04
Noida Airport Gets Security Clearance for Licence
Noida International Airport receives security clearance from BCAS, paving the way for aerodrome licence. Operations to begin soon.
Mar 05, 2026 22:45
IBM Launches Innovation Center in India
IBM launches Sangam Infrastructure Innovation Centre in India to co-create AI solutions with clients and partners.
Mar 05, 2026 22:14
UPL Restructuring: Retains Speciality Chemical Revenue
UPL Ltd to retain revenue from Superform after restructuring. Aims to create UPL Global, a pure-play crop protection platform.
Mar 05, 2026 22:10
Samsung India R&D & Galaxy S26 Development
Samsung's India R&D centers played a key role in Galaxy S26 development. Bengaluru & Noida centers crucial for AI & localization.
Mar 05, 2026 21:58

More News »

Top News

Delhi Excise Revenue: Rs 4,992 Crore
Delhi excise department collected Rs 4,992 crore revenue by January-end. Revised target is Rs 6,000 crore by March. Details here.
Mar 06, 2026 00:04
BEL & Bellatrix to Develop VLEO Technologies
BEL and Bellatrix Aerospace partner to develop satellite technologies for Very Low Earth Orbit (VLEO). Advancing India's space capabilities.
Mar 05, 2026 23:17
Noida Airport Gets Security Clearance for Licence
Noida International Airport receives security clearance from BCAS, paving the way for aerodrome licence. Operations to begin soon.
Mar 05, 2026 22:45
Fractal Analytics Q3 Profit Rises 8.5% to Rs 100 Cr
Fractal Analytics reports 8.5% profit growth to Rs 100 crore in Q3 2025. Revenue up 21% driven by healthcare and financial services.
Mar 05, 2026 22:34
IBM Launches Innovation Center in India
IBM launches Sangam Infrastructure Innovation Centre in India to co-create AI solutions with clients and partners.
Mar 05, 2026 22:14

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com